SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $30,896,074 | +12.4% | 16,522,000 | 0.0% | 0.08% | +1.2% |
Q3 2022 | $27,479,000 | -21.3% | 16,522,000 | -40.4% | 0.08% | -26.3% |
Q2 2022 | $34,935,000 | +33.1% | 27,732,000 | +38.7% | 0.11% | +37.3% |
Q1 2022 | $26,244,000 | +79.6% | 20,000,000 | +100.0% | 0.08% | +66.0% |
Q4 2021 | $14,609,000 | -1.5% | 10,000,000 | 0.0% | 0.05% | -19.4% |
Q3 2021 | $14,826,000 | – | 10,000,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |